Home / Latest Science News -- ScienceDaily / Experimental antiviral for COVID-19 effective in hamster study

Experimental antiviral for COVID-19 effective in hamster study

The experimental antiviral drug MK-4482 significantly decreased levels of virus and disease damage in the lungs of hamsters treated for SARS-CoV-2 infection, according to a new study. MK-4482, delivered orally, is now in human clinical trials.

from Latest Science News -- ScienceDaily https://www.sciencedaily.com/releases/2021/04/210416120127.htm
Experimental antiviral for COVID-19 effective in hamster study Experimental antiviral for COVID-19 effective in hamster study Reviewed by cmakigo on April 17, 2021 Rating: 5

You May Also Like

No comments:

Post a Comment

Subscribe to: Post Comments ( Atom )
'; (function() { var dsq = document.createElement('script'); dsq.type = 'text/javascript'; dsq.async = true; dsq.src = '//' + disqus_shortname + '.disqus.com/embed.js'; (document.getElementsByTagName('head')[0] || document.getElementsByTagName('body')[0]).appendChild(dsq); })();
Powered by Blogger.